Pneumococcal Polysaccharide Vaccination Among Patients With Diabetes, Asthma, and Cigarette Use

Download item | Update item information
Identifier EBP2016_poster_TROVATO
Title Pneumococcal Polysaccharide Vaccination Among Patients With Diabetes, Asthma, and Cigarette Use
Creator Anthony Trovato, PharmD Candidate, University of Utah College of Pharmacy, Salt Lake City; Karen Gunning, PharmD, BCPS, BCACP, University of Utah College of Pharmacy, Salt Lake City, University of Utah Health Care Sugarhouse Family Practice Clinic, Salt Lake City; Karly Pippitt, MD, FAAFP, University of Utah Health Care Sugarhouse Family Practice Clinic, Salt Lake City, University of Utah School of Medicine, Salt Lake City
Description Streptococcus pneumoniae infection results in a variety of illnesses including ear and sinus infections, meningitis, and pneumonia. The Pneumovax 23 Vaccine (pneumococcal polysaccharide vaccine or PPSV23) helps protect against 23 strains of S. pneumoniae, and is indicated in adults 65 years old and older, children 2 years old and older at high risk for infection, and in those 19 to 64 years old who smoke or have asthma. Health care providers assess the risk of pneumococcal disease in each patient and administer the vaccination if indicated.
Subject Pneumococcal Polysaccharide Vaccination; Diabetes; Asthma; Cigarette Use
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2016
Date Digital 2016
Language eng
ARK ark:/87278/s6c57zct
Relation is Part of Evidence-Based Multidisciplinary Projects 2016
Format application/pdf
Setname ehsl_ebp
Date Created 2019-02-05
Date Modified 2019-07-09
ID 1399610
Reference URL https://collections.lib.utah.edu/ark:/87278/s6c57zct
Back to Search Results